Heparin Sodium Injection, Solution
Product Images NDC 0781-3545

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Heparin Sodium (NDC 0781-3545). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Heparin-fig1 (Heparin Fig1)

This description provides information about a pharmaceutical product with the National Drug Code (NDC) 0781-3545-10, derived from Porcine Intestinal Mucosa. The product is described as sterile and nonpyrogenic and is distributed by Sandoz in Princeton, NJ. It comes in a multiple-dose vial with a concentration of 5,000 USP Units/mL for IV or SC use, to be stored at 20°C to 25°C. The expiration date is in May 2024.*

FDA Label Image

Heparin-fig10 (Heparin Fig10)

FDA Label Image

Heparin-fig11 (Heparin Fig11)

This is a description of a pharmaceutical product with the National Drug Code (NDC) 0781-3541-10 used to deliver HEPARIN extracted from Porcine Intestinal Mucosa. The product is indicated for intravenous (IV) or subcutaneous (SC) use, and it is described as sterile and nonpyrogenic. The product is a sodium-based injection stored at a recommended temperature range of 20° to 25°C. The manufacturer is Sandoz Inc. located in Princeton, New Jersey, as shown on the label. It is a multiple-dose vial with a given expiry date.*

FDA Label Image

Heparin-fig12 (Heparin Fig12)

This text appears to be a detailed description of a sterile, nonpyrogenic solution containing heparin sodium for injection. The solution also contains methylparaben, propylparaben, and water for injection. The text provides information on dosage, storage instructions, and safety precautions. It includes details about the manufacturer (Shenzhen Techdow Pharmaceutical Co., Ltd.), distributor (Sandoz Inc.), and production date. The solution is advised to be used only if clear and seal intact. It also mentions that the container closure does not contain natural rubber latex.*

FDA Label Image

Heparin-fig13 (Heparin Fig13)

This text contains important information related to a medication with the NDC 0781-3543-10 code intended for Rx-only use, derived from Porcine Intestinal Mucosa. It is HEPARIN, a sterile, nonpyrogenic medication. The storage instructions recommend keeping it at 20° to 25°C (68° to 77°F). This medication comes in a 30 mL multiple-dose vial with a concentration of 30,000 USP Units/30 mL (1,000 USP Units/mL). It is suitable for IV or SC use. The drug should be kept out of reach of children and is distributed by Sandoz Inc. in Princeton, NJ 08540. The lot number is also provided in the text.*

FDA Label Image

Heparin-fig14 (Heparin Fig14)

This is a product label for a sterile and nonpyrogenic solution containing heparin sodium, sodium chloride, methylparaben, and propylparaben. Each mL of the solution is isotonic with sodium and should only be used if the solution is clear and the seal is intact. The container closure is not made from natural rubber latex. The product is manufactured in China by Shenzhen Techdow Pharmaceutical Co., Ltd., and distributed by Sandoz Inc. It is advised to store the solution at 20° to 25°C and keep out of reach of children. Additional information such as dosage recommendations can be found in the insert.*

FDA Label Image

Heparin-fig15 (Heparin Fig15)

This is a description of a medication that is a Heparin Sodium Injection with a strength of 50,000 USP Units in 5 mL solution. It is derived from porcine intestinal mucosa and is sterile and nonpyrogenic. The medication is stored at a temperature of 20° to 25°C and is distributed by Sandoz Inc. This product is a prescription medication meant for use in medical settings.*

FDA Label Image

Heparin-fig16 (Heparin Fig16)

This document appears to be a label or packaging information for a pharmaceutical product. It includes details about the content of the product, storage instructions, dosage information, and manufacturer details. The product seems to be a sterile, nonpyrogenic solution containing heparin sodium, methylparaben, and propylparaben. Users are advised to store the solution within a specific temperature range, away from children, and to inspect the solution prior to use. The product appears to be manufactured by Shenzhen Techdow Pharmaceutical Co., Ltd., distributed by Sandoz Inc., and produced in China.*

FDA Label Image

Heparin-fig17 (Heparin Fig17)

This is a description for Heparin Sodium Injection, USP which contains 50,000 USP Units in 10 mL. It is a sterile and nonpyrogenic solution derived from Porcine Intestinal Mucosa. This medication is intended for intravenous or subcutaneous use. It should be stored at a temperature between 20°C to 25°C (68°F to 77°F). The product includes a warning that it contains Benzyl Alcohol and is in a multiple-dose vial. This medication is distributed by Sandoz Inc. and has an expiration date of May 2024.*

FDA Label Image

Heparin-fig18 (Heparin Fig18)

FDA Label Image

Heparin-fig2 (Heparin Fig2)

FDA Label Image

Heparin-fig3 (Heparin Fig3)

This text appears to be a label for a medical product. It seems to be a heparin injection derived from Porcine Intestinal Mucosa, indicated for intravenous (IV) or subcutaneous (SC) use. The product is stated to be sterile, nonpyrogenic and preservative-free. It should be stored at 20-25°C and distributed by Sandoz Inc. in Princeton, NJ. The packaging is a single-dose vial and the unused portion should be discarded. The expiration date is not available, as the text appears to be cut off.*

FDA Label Image

Heparin-fig4 (Heparin Fig4)

FDA Label Image

Heparin-fig5 (Heparin Fig5)

This is a product description for HEPARIN SODIUM 1,000 USP Units/mL Injection indicated for IV or SC use. It is derived from Porcine Intestinal Mucosa and is sterile and nonpyrogenic. The medication comes in a multiple-dose vial and should be stored at 20° to 25°C (68° to 77°F). Manufactured by Sandoz Inc. in Princeton, NJ.*

FDA Label Image

Heparin-fig6 (Heparin Fig6)

FDA Label Image

Heparin-fig7 (Heparin Fig7)

Description: This text provides information about a drug called Heparin Sodium, which is derived from Porcine Intestinal Mucosa. It is a sterile and nonpyrogenic medication meant for intravenous (IV) or subcutaneous (SC) use. The drug should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and kept out of the reach of children. The drug is distributed by Sandoz Inc., and the text includes details on the drug's National Drug Code (NDC) number, prescription-only status, and packaging as a multiple-dose vial. Note: Some parts of the text are illegible or missing.*

FDA Label Image

Heparin-fig8 (Heparin Fig8)

This text provides information about a pharmaceutical product from China manufactured by Shenzhen Techdow Pharmaceutical Co., Ltd. It includes details about the distributor (Sandoz Inc.), storage instructions, composition of the product, warnings, and dosage information. The product seems to be a solution containing heparin sodium, sodium chloride, methylparaben, and propylparaben among other components. It is sterile and nonpyrogenic, and the container closure is not made from natural rubber latex. The text also emphasizes keeping the product out of reach of children.*

FDA Label Image

Heparin-fig9 (Heparin Fig9)

This is a description of a pharmaceutical product with the National Drug Code (NDC) 0781-3439-10 derived from Porcine Intestinal HEPARIN Mucosa. It is stated to be sterile, nonpyrogenic, and recommended to be stored between 20°C to 25°C (68°F to 77°F). This Sodium Injection, USP distributed by Sandoz Inc. in Princeton, NJ is labeled for IV or SC use and comes in a multiple-dose vial. The information includes important details about usage and storage.*

FDA Label Image

Heparin Chemical Structure (Heparin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.